The U.S. Defense Logistics Agency (DLA) awarded a $6,399.12 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566343564 units of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product. This delivery order falls under Dakota Drug's existing indefinite delivery contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which supports the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date of November 6, 2024, and was awarded on November 5, 2024. The contract has no set-aside designation, indicating Dakota Drug, Inc.'s strong competitive position in the federal medical supply marketplace.
Generated 2/4/25, 10:36 AM